123 related articles for article (PubMed ID: 38553357)
1. Clinical characteristics and prognosis of SARS-CoV-2 infection in children with hematological malignancies: A multicenter, retrospective study in China.
Wang W; Xu X; Bai S; Wang L; Luo J; Zhao D; Li P; Fan Q; Wang C; Yao Q; Li B; Wang D
Pediatr Neonatol; 2024 Mar; ():. PubMed ID: 38553357
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients.
Haeusler GM; Ammann RA; Carlesse F; Groll AH; Averbuch D; Castagnola E; Agyeman PKA; Phillips B; Gilli F; Solopova G; Attarbaschi A; Wegehaupt O; Speckmann C; Sung L; Lehrnbecher T
Eur J Cancer; 2021 Dec; 159():78-86. PubMed ID: 34736044
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study.
Uka A; Buettcher M; Bernhard-Stirnemann S; Fougère Y; Moussaoui D; Kottanattu L; Wagner N; Zimmermann P; Ritz N;
Eur J Pediatr; 2022 Mar; 181(3):1245-1255. PubMed ID: 34845526
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Outcomes of Children With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Admitted to a Quaternary Hospital: A Single-Center Experience.
Alshehri SS; Minhaji BI; Pasha MR; Fouda D; Joseph J; Ahmed N
Cureus; 2024 Jan; 16(1):e52532. PubMed ID: 38371066
[TBL] [Abstract][Full Text] [Related]
6. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of children with coronavirus disease 2019 Delta variant infection after vaccination with inactivated SARS-CoV-2 vaccine].
Su H; Zhang X; Duan FY; Ren XQ; Yan YB; Ding Y
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):742-747. PubMed ID: 35894187
[TBL] [Abstract][Full Text] [Related]
9. The Burden of COVID-19 in Adult Patients With Hematological Malignancies: A Single-center Experience After the Implementation of Mass-vaccination Programs Against SARS-CoV-2.
Rapti V; Papanikolopoulou A; Kokkotis G; Livanou ME; Alexiou P; Pechlivanidou E; Syrigos NK; Spernovasilis N; Charpidou A; Poulakou G
In Vivo; 2023; 37(6):2743-2754. PubMed ID: 37905643
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.
El Aidaoui K; Haoudar A; Khalis M; Kantri A; Ziati J; El Ghanmi A; Bennis G; El Yamani K; Dini N; El Kettani C
Cureus; 2020 Sep; 12(9):e10716. PubMed ID: 33033687
[TBL] [Abstract][Full Text] [Related]
11. Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19.
Jabr R; Khatri A; Anderson AD; Garcia LC; Viotti JB; Natori Y; Raja M; Camargo JF; Morris MI
Transpl Infect Dis; 2023 Feb; 25(1):e14006. PubMed ID: 36704987
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.
Tabata S; Imai K; Kawano S; Ikeda M; Kodama T; Miyoshi K; Obinata H; Mimura S; Kodera T; Kitagaki M; Sato M; Suzuki S; Ito T; Uwabe Y; Tamura K
Lancet Infect Dis; 2020 Sep; 20(9):1043-1050. PubMed ID: 32539988
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
14. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
Yue H; Bai X; Wang J; Yu Q; Liu W; Pu J; Wang X; Hu J; Xu D; Li X; Kang N; Li L; Lu W; Feng T; Ding L; Li X; Qi X;
Ann Palliat Med; 2020 Jul; 9(4):1404-1412. PubMed ID: 32692208
[TBL] [Abstract][Full Text] [Related]
17. Impact of SARS-CoV-2 infection on patients with hematological malignancies: a retrospective study.
Zhao H; He Y; Li Z; Huang Y; Ying Y; Huang Z
Hematology; 2023 Dec; 28(1):2288480. PubMed ID: 38063157
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.
Xiong S; Liu L; Lin F; Shi J; Han L; Liu H; He L; Jiang Q; Wang Z; Fu W; Li Z; Lu Q; Chen Z; Ding S
BMC Infect Dis; 2020 Oct; 20(1):787. PubMed ID: 33092539
[TBL] [Abstract][Full Text] [Related]
20. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
